Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Washington University School of Medicine
With
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Scheduled to receive neoadjuvant chemotherapy for the treatment of newly diagnosed, locally advanced breast cancer or scheduled to receive neoadjuvant endocrine therapy with the eventual goal of surgery of newly diagnosed clinical stage II-III ER+ HER2- breast cancer (for the endocrine therapy cohort)
At least 18 years of age
Female
Able to understand and willing to sign an IRB-approved written informed consent document
You may not be if
Pregnant and/or breastfeeding
Prior history of breast cancer
Prior history of chest wall radiation
Prior history of breast reconstruction, reduction, or augmentation
Clareo Health | Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment
